chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pneumonia; Initial information was received on 05-Oct-2021 regarding an unsolicited valid serious case from social media via consumer/non-health care professional.   This case involves a patient (unknown demographics) who had pneumonia after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.   Medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date in 2009, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a serious pneumonia (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant. The patient was hospitalized for this event.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.   It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event pneumonia.  Information on batch number was requested for this case.; Sender's Comments: This case concerns a patient (unknown demographics) who had pneumonia after vaccination with INFLUENZA VACCINE (unknown manufacture). The time to onset is unknown. Additional information regarding patient's medical history, condition at the time of vaccination and laboratory data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
This spontaneous report was received from an office manager, who referred to a 36-year-old male patient. No information regarding the patient's pertinent medical history, concurrent conditions and drug reactions or allergies was provided. On 03-OCT-2017, the patient was vaccinated with GARDASIL via intradermal route (lot# M014929, expiration date: 27-MAY-2017; dose and anatomical location were not reported) instead of the recommended intramuscular route. No adverse effects were reported. No product quality complaint was involved.
Had flu-like symptoms night of shot. Fever and pain, plus arm pain. She thought shot was given rather high on shoulder.
First dose in 2020, second dose on 5/3/2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) (batch number DC434, expiry date 3rd June 2023) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 2020 from another pharmacy.).   On 3rd May 2022, the patient received the 2nd dose of Shingrix. On 3rd May 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 12-AUG-2022 Reporter's Comment: The reporter was a pharmacist. The reporter stated that the patient received Shingrix Vaccine. The patient received 1st dose in 2020 at another pharmacy and then received 2nd dose on 03-May-2022 at reporter pharmacy. The reporter did not consent to follow up. Additional supportive information: The patient received 2nd dose of Shingrix late than recommended time frame, which led to lengthening of vaccination schedule.
Chills; Urinating (More often); This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and POLLAKIURIA (Urinating (More often)) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced CHILLS (Chills) and POLLAKIURIA (Urinating (More often)). At the time of the report, CHILLS (Chills) and POLLAKIURIA (Urinating (More often)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient went to the ER because his elbow swelled below injection site. He was placed on antibiotics.
Heart inflammation, shortness of breath, numbness of left arm, sharp pains in left arm, tightness in chest.
75-year-old male presenting as per HPI with generalized weakness and fatigue.   Initially, he was somewhat hypotensive with a pressure in the 80s systolic.  Review of records, this is not patient's normal blood pressure.  He was initially started on IV fluids, as on review of records, he does have a history of significant CHF, although his ejection fraction is grossly normal.  He had some improvement with 500 mL, and then had better improvement with an additional 500 mL bolus, and his blood pressure stabilized.   Initial concern would be for sepsis versus dehydration versus CHF.  Less likely CHF with volume overload, as he does not clinically appear volume overloaded, his BNP is minimally elevated, and approximately baseline for him.  Lungs are clear, he has no lower extremity edema.  Septisol console considered, although again less likely, as he has no leukocytosis, his lactate is normal and he has no significant electrolyte abnormalities.  Urinalysis reassuring, respiratory viral panel negative.   Most likely, patient is having side effects related to his recent COVID-19 vaccine, causing decreased oral intake, which then led to generalized weakness, fatigue and hypotension.  Patient does have some significant lab abnormalities which include an elevated troponin at 0.07 (baseline 0.03), and a mild AKI with a creatinine of 1.33 (baseline around 1).  Imaging overall reassuring, chest x-ray shows no focal consolidations or evidence of fluid overload or pneumonia, CT scan of the head reassuring, with some chronic ischemic changes, but no acute findings.   With regards to patient's left shoulder pain, he has no significant tenderness to the left shoulder, and I suspect this is a vaccine site reaction.  He has normal range of motion of the shoulder, does not report any recent trauma to make me suspicious for any traumatic injuries or other acute pathology related to his shoulder.  More concerning  is that this could be an anginal equivalent, and while EKG is reassuring, we will plan to hospitalize pt for further ACS work-up.   Given hypotension, generalized weakness, and the fact the patient is having difficulty ambulating, doubt to consult the hospitalist for further evaluation and management.
This spontaneous report as received from a registered nurse refers to a 35 years old female patient. The patient was inadvertently vaccinated with a 0.5 ml PROQUAD (Lot # reported as H015631, exp 23-FEB-2014) subcutaneously in the left arm on 12-OCT-2012 instead of MMR II. No adverse effects were reported at this time. Additional information has been requested.
Pt reported allergic reaction with hives down her arm, entire arm red, warm, itchy & swollen.
Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Tinnitus-Mild, Additional Details: Pt reported that she had not eaten before getting vaccination. Pt stated she felt lightheaded/dizzy right after vaccination adminstration. Pt stated she had ringing in her ears and then fainted while seated. Pt regained consciousness and became sweaty. Pt drank water and ate a bar with nuts.  After sitting a few minutes she said the ringing in her ears had stopped and she felt better.  She was able to stand and walk to another chair.  After drinking additional water, she left store with parent.
Bell's Palsy left side of face  20 mg Prednisone 1 gm Valacyclov-IR
1 week after booster shot he began to look dehydrated and was complaining of blurred vision. We took him to Urgent care because he was loosing weight. Tests showed a blood sugar level over 700. He was hospitalized and diagnosed with Diabetes Type 1.
Severe arm/ injection sight pain, dizziness, fatigue, nausea, chills, and body aches. The first wave came on around 11:00am and lasted until 2:00pm when they began to resolve. Then a second wave began around 5:00pm and didn?t fully resolve until 4:00pm the following day 5/12/2021
Client also reports a reaction she believes is from her flu shot given on 1-23-19. Client states approximately one week after injection, she devoloped pains in her left buttock, left flank, and left thigh. She reports a fever of 101, productive cough, and poor appetite for 3 days. Client states she did not present to a clinic. She is unsure if this is a reaction to the immunization or possible contact with someone with influenza prior to her body reaching full immunity to the flu. Client states she always has a minor local reaction of pain and soreness at the injection site. This time she had injection on left hip, which she thinks would explain the pains she had on her left side. Of note, documentation states the injection was received in right deltoid. Currently she feels fully recovered.
Patient developed varicella disease after he had received 2 doses of the vaccine. He was seen in our office 4/11/16 with pruritic spreading, scabbing rash on face, neck, abdomen, and extremities x 4 days. New lesions continue to develop.
Information has been received from a medical assistant concerning a 74 year old female who on 16-APR-2007 was vaccinated with Zostavax. On 23-APR-2007, the patient experienced an itchy rash not at the injection site (not further specified). The patient had not recovered.
Moderna COVID-19 Vaccine EUA.  At approximately 4:30 p.m. while at home, I felt pressure in my chest, shortness of breath.  After the symptoms became worse, I was driven to the Emergency Department for treatment.  My initial blood pressure was 247/114.  I was administered aspirin iohexol (OMNIPAQUE) and nitroglycerin (NITROSTAT).  I was given oxygen.  Blood was drawn, an EKG standard was taken, a CTA Chest scan was done and a XR Chest 2 View PA and Lateral were taken. I was released from the hospital at approximately 11:30 p.m.  My blood pressure at the time was 187/107.  My breathing was easier and my chest pain was low.
Information has been received from a pharmacist concerning a 71 year old female with a history of shingles 2 years ago and no allergies, who on 09-JUN-2008 was vaccinated subcutaneously with a dose of ZOSTAVAX (lot number 659615/0162X) (injection site not reported). Concomitant therapy included Omeprazole, Lisinopril (manufacturer unknown), Levothyroxine Na and Losartan potassium-HCTZ (MSD). On 25-JAN-2009 the patient was diagnosed with possible chickenpox. The patient broke out with pimple bumps over the entire body (torso and head included), sometimes there were little patches. The patient had a high blood pressure of 212/106 and the patient had a lot of discomfort. The patient's husband visited the pharmacist. Subsequently the patient was hospitalized due to recommendation by the pharmacist. Laboratory tests included a lot of blood work (results unspecified). At time of this report, the patient's events persisted. High blood pressure was considered to be an other important medical event by the pharmacist. This is one of several reports received from the same source. Additional information has been requested.
adult patient received pediatric instead of adult dose; adult patient received pediatric instead of adult dose; This case was reported by a nurse via call center representative and described the occurrence of accidental underdose in a 44-year-old female patient who received HAV (Havrix pediatric) (batch number J95H7, expiry date 22nd May 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Havrix (1st dose received in June 2021).   On 17th December 2021, the patient received Havrix pediatric and Havrix Pre-Filled Syringe Device. On 17th December 2021, unknown after receiving Havrix pediatric and Havrix Pre-Filled Syringe Device, the patient experienced accidental underdose and adult use of a child product. On an unknown date, the outcome of the accidental underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The registered nurse reported that, the adult patient received pediatric dose of Havrix in error, which led to accidental underdose and adult use of a child product. This dose was given as a booster. The reporter consented to follow up. The case is one of four cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021247333:Same reporter US-GLAXOSMITHKLINE-US2018GSK027335:Same reporter US-GLAXOSMITHKLINE-US2018014434:Same reporter
very sick; Initial information received on 06-Dec-2020 regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (patient).  This case involved an adult patient of an unknown age and gender who got very sick (illness), after receiving INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date and other dosing details were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, unknown latency, the patient stated that flu vaccine always made me very sick (illness).   No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome of the event was reported as unknown.  There will be no information available on the batch number for this case.
Information has been received from a physician concerning a 14 year old female pt, who was vaccinated with varicella virus vaccine, live . The physician reported that out of 10 children vaccinated with varicella virus vaccine, live one female failed to seroconvert after a titer was drawn. The physician mentioned the lot numbers were different, but he had no information as to whether TX was required. No other additional information wa available. There was no product quality complaint reported. Unspecified medical attention was sought. Additional information has been requested. The physician also mentioned that 3 male children out of 10 children vaccianted with varicella virus vaccine, live failed to seroconvert after a titer was drawn (WAES# 0406USA00335). Additionally, the physician mentioned that some clients vaccinated with measles virus vaccine live + mumps virus vaccine, live + rubella virus vaccine live are not immune to either mumps or rubella when older (WAES# 0406USA1779).
1 day following vaccination, child developed erythema and edema of lower, lateral aspect of upper right arm, in region of subcutaneous varicella vaccine administration.  Patient seen on 6/3/2009 with same complaint and diagnosed with moderate local vaccine reaction.  Parent advised to administer oral diphenhydramine to patient to reduce local swelling. By phone report on 6/4/2009, swelling has decreased; no new symptoms.
71 y/o F presents to the clinic with chief complaint of generalized urticaria. Symptoms began 2 days ago, a total of 4 days after her original vaccination date with her second booster dose of Moderna Vaccine. Treatment was recommended with an antihistaminic agent, and she was instructed to visit her primary physician in case of worsening symptoms.
Severe lymph node swelling under vaccinated arm after the second dose.  Lasted 9 days; This is a spontaneous report from a contactable consumer (patient) communicated to a Pfizer representative (pharmacist). This 54-year-old female patient received dose 2 of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) via an unspecified route on an unspecified date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 on 04Jan2021 and experienced arm where  she received vaccine was sore and very heavy. On an unspecified date, after the second dose of BNT162B2, the patient experienced severe lymph node swelling under the vaccinate d arm that lasted 9 days. The outcome of severe lymph node swelling under the vaccinated arm was recovered.   No follow-up attempts are possibele. Information about lot number cannot be obtained.
Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022; Received vaccine past its 30-days Exp date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2022 at 10:12 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Feb-2022 at 10:12 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.  It was reported that a series of an approximately 540 patients had received lot number of 066H21A in past and had an its 30 days of an expiry date. The vaccine was administered up until its manufactured expiry date of 04-Apr-2022 and this lot number was no longer possessed. No treatment medications were reported.   This case was linked to MOD-2022-542869 (Patient Link).
eyelids are a little swollen; This is spontaneous report from a contactable consumer. An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, "Pfizer vaccine" as reported, lot number: unknown), via an unspecified route of administration on an unspecified date (06:30AM) at single dose for Covid-19 immunization. The patient's medical history included allergy to antibiotics (reported as "she is allergic to other things, but they are antibiotics"). Concomitant medications were not reported. The patient reported that she had the vaccine at 6:30AM (unspecified date) which she thought was Moderna (pending clarification). She clarified that she was supposed to get Pfizer's but that she thought that she was allergic to some of things in it (pending clarification). She further stated that her eyelids are a little swollen on an unspecified date. She did not know if she should take Benadryl or what. She reported that she was having slight reaction to the shot. She stated that she is allergic to other things, but they are antibiotics. The outcome of event was unknown.  Information on lot/batch number has been requested.
Client came to clinic at 11:45 am at 2/25/04 complained of affected arm 2 prime vaccination of flu vaccine in 11/03. Asked client why she waited to Follow up arm pain and loss of range of motion- client had no response. Referred to Private medical doctor to determine cause and treatment.
Information has been received from a nurse practitioner concerning a female patient with an allergy to grapes who was vaccinated with a dose of Gardasil. Subsequently, the patient experienced an anaphylactic reaction. Upon further contact with the patient, the patient shared she had eaten grapes at an Italian restaurant and that "was what caused the reaction." At the time of this report, the patient's outcome was unknown. Additional information has been requested.
chills; fatigue; headache; arm soreness; nausea; Tingling in lips/mouth; itching; low grade fever; vomiting; This is a spontaneous report from a non-contactable consumer (patient). A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number=14-202012170004), via an unspecified route of administration on right arm on 17Dec2020 at single dose for COVID-19 immunization. Medical history reported as none. Concomitant medication included sertraline hydrochloride (ZOLOFT) and minerals nos, vitamins nos (PRENATAL VITAMIN). The patient experienced tingling in lips/mouth, itching, nausea, vomiting, chills, headache, low grade fever, fatigue, arm soreness on 17Dec2020, all events reported as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The patient did not receive any treatment for all events. The outcome of events was recovered in Dec2020.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
This report was received from Pfizer with manufacturer control number# 2015005953 on 21-JAN-2015. This report was originally received from a pharmacist, an elderly male in his sixties, regarding himself. The patient's medical history included receiving his second PREVNAR 7 booster dose about two years ago, when he was 62 or 63 years old. On an unknown date, one year ago, the pharmacist had the wrong vaccine administered to him, he had asked his doctor for PREVNAR 13 but his doctor gave him PNEUMOVAX 23 instead. This was an unusual regimen for the pharmacist. Limited information was available as the pharmacist disconnected the call before he could be transferred to medical information department. The outcome of wrong vaccine administration was unknown. Additional information is not expected since there was no request for medical information.
As per Vaccine recipient -incident happened at home , Initial onset of dizziness, shortness of breath and heart racing. Then respirations were slowing and patient  felt like she was going to pass out , like that pending doom sort of feeling. Patient turned very pale and was presenting black and bluish under her eye region with blue lips. At that time ,she tried to hyper ventilate herself to pink back up again, after a few minutes she regained color but was still very weak and was trembling, her respirations returned to mostly normal at that time me . She laid down to rest and then her toes started involuntarily twitching , they eventually stopped after 10-15.Whole episode lasted about half hour to 45 mins.
This is a spontaneous report received from a contactable physician. A 57-year-old female patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# ER8732), at the age of 57, intramuscularly, in right arm, on Mar 28, 2021, single dose, for COVID-19 immunisation. Medical history included dyspepsia (unspecified if ongoing). Concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# EN6206), at the age of 57, intramuscularly, in left arm, on Mar 7, 2021, at noon, single dose, for COVID-19 immunisation. The patient experienced herpes zoster (shingles), onset Apr 2021, with outcome of recovered (May 2021). Additional information: Dose: 2nd. Date: Mar 28, 2021; Time: Noon. Follow-up attempts  completed. No further information expected.